‘March Cannabis Sales Remained Flat Sequentially’ -Earlier Article From Alan Brochstein’s New Cannabis Ventures
https://www.newcannabisventures.com/march-cannabis-sales-remained-flat-sequentially/
Cannabis Stocks Quiet Following Tweet From Politico Reporter Senate Democrat Pat Murray Said House’s Cannabis Banking Provision Staying In COMPETES Act Is A Top Priority
https://twitter.com/natsfert/status/1519324409516990464
LEXX: Hypertension Results Raise Stakes
By John Vandermosten, CFA
NASDAQ:LEXX
READ THE FULL LEXX RESEARCH REPORT
Breaking: Avicanna’s Cannabinoid Drugs To Reach Brazil Via Its First ‘Big Pharma’ Deal
Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development and commercialization of plant-derived medical…
‘Michigan Reports Cannabis Sales Grew Just 5% in March’ -Article From Alan Brochstein’s New Cannabis Ventures
https://www.newcannabisventures.com/michigan-reports-cannabis-sales-grew-just-5-in-march/
Syros’ CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies
Syros Pharmaceuticals Inc (NASDAQ: SYRS)
Jazz Pharmaceuticals Presents Pre-clinical Data For Pan-RAF Inhibitor JZP815, Including Pharmacokinetic Properties And Efficacy In Multiple Solid Tumor Types
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and collaboration partner Redx Pharma (AIM: REDX) today presented data showing the pan-RAF kinase inhibitor, JZP815, was active in multiple RAF- and RAS-mutant tumor
Werewolf Therapeutics Shares Jump On Cancer Product Pact With Jazz Pharma
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has acquired exclusive global development and commercialization rights to Werewolf Therapeutics Inc’s (NASDAQ:HOWL) WTX-613. WTX-613 is a differentiated, conditionally-activated…